Vascular Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Midterm Oncologic Outcomes.

Lebdai, Souhil; Bigot, Pierre; Leroux, Pierre-Adrien; Berthelot, Louis-Paul; Maulaz, Pierre; Azzouzi, Abdel-Rahmene

Lebdai, Souhil; Bigot, Pierre; Leroux, Pierre-Adrien; Berthelot, Louis-Paul; Maulaz, Pierre; Azzouzi, Abdel-Rahmene.

Afiliación

Lebdai S; Urology Department, University Hospital of Angers, Angers, France. Electronic address: souhil.lebdai@gmail.com.
Bigot P; Urology Department, University Hospital of Angers, Angers, France.
Leroux PA; Urology Department, University Hospital of Angers, Angers, France.
Berthelot LP; Urology Department, University Hospital of Angers, Angers, France.
Maulaz P; Urology Department, University Hospital of Angers, Angers, France.
Azzouzi AR; Urology Department, University Hospital of Angers, Angers, France.

J Urol ; 198(2): 335-344, 2017 08.

Article en En | MEDLINE | ID: mdl-28322857

Asunto(s)

Bacterioclorofilas/uso terapéutico; Fotoquimioterapia; Neoplasias de la Próstata/tratamiento farmacológico; Neoplasias de la Próstata/patología; Anciano; Estudios de Seguimiento; Humanos; Masculino; Persona de Mediana Edad; Supervivencia sin Progresión; Estudios Prospectivos; Antígeno Prostático Específico/sangre; Neoplasias de la Próstata/mortalidad; Tasa de Supervivencia; Resultado del Tratamiento

Palabras clave

WST11 compound; photochemotherapy; prostatic neoplasms; therapeutic occlusion; treatment outcome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fotoquimioterapia / Neoplasias de la Próstata / Bacterioclorofilas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google